Ukraine Pharmaceuticals and Healthcare Report Q3 2012

  • ID: 2199843
  • June 2012
  • Region: Ukraine
  • 81 pages
  • Business Monitor International
1 of 3

The Ukraine Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with independent forecasts and competitive intelligence on Ukraine's pharmaceuticals and healthcare industry.

BMI View: Ukraine remains one of Central and Eastern Europe’s promising pharmaceutical markets, but its chronic lack of economic and political stability remains a critical impediment to fulfilling this potential. The country’s economy remains vulnerable to contagion from the European Union (EU)’s economic crisis as indicated by slowing economic growth in Q112. Continued lack of investment in the healthcare system translates into a pharmaceutical market driven by out-of-pocket purchasing and hence the market remains exposed to the country’s volatile economy and currency. Despite these major challenges, the market retains outsize promise due to the country’s favourable geographic position between the EU and the Commonwealth of Independent State (CIS), large population and pent-up demand for modern treatments.

Headline Expenditure Projections

Note: Product cover images may vary from those shown
2 of 3

Executive Summary 5

SWOT Analysis 8

Ukraine Pharmaceutical And Healthcare Industry SWOT 8

Ukraine Political SWOT 9

Ukraine Economic SWOT 9

Ukraine Business Environment SWOT 10

Pharmaceutical Risk/Reward Ratings 11
Table: Emerging Europe – Regional Pharmaceutical Risk/Reward Ratings, Q312 11

Rewards 12

Risks 13

Ukraine – Market Summary 14

Regulatory Regime 16

Intellectual Property Issues 18

Pricing and Reimbursement Issues 20

Other Market Entry Barriers 26

Industry Developments 27

Medical Devices 29

Industry Forecast Scenario 30

Overall Market Forecast 30
Table: Pharmaceutical Sales Indicators 2008-2016 32

Key Growth Factors – Industry 33
Table: Healthcare Expenditure Indicators 2008-2016 37
Table: Healthcare Governmental Indicators 2008-2016 37
Table: Healthcare Private Indicators 2008-2016 38

Key Growth Factors – Macroeconomic 39

Prescription Drug Market Forecast 42
Table: Prescription Drug Sales Indicators 2008-2016 43

Patented Drug Market Forecast 44
Table: Patented Drug Market Indicators 2008-2016 45

Generic Drug Market Forecast 46
Table: Generic Drug Sales Indicators 2008-2016 47

OTC Medicine Market Forecast 48
Table: OTC Medicine Sales Indicators 2008-2016 49

Pharmaceutical Trade Forecast 50
Table: Exports and Imports Indicators 2009-2016 52

Medical Device Market Forecast 53
Table: Medical Device Sales Indicators 2008-2016 54

Competitive Landscape 55

Manufacturing Sector 55

Recent Company Activities 60

Wholesale 60

Retail 61

Company Profiles 63

Arterium 63

Gedeon Richter 65

Krka 67

Lek (Novartis/Sandoz) 69
Table: Ukraine’s Population By Age Group, 1990-2020 (‘000) 72
Table: Ukraine’s Population By Age Group, 1990-2020 (% of total) 73
Table: Ukraine’s Key Population Ratios, 1990-2020 74
Table: Ukraine’s Rural And Urban Population, 1990-2020 74

Glossary 75

BMI Methodology 77

How We Generate Our Pharmaceutical Industry Forecasts 77

Pharmaceuticals Risk/Reward Ratings Methodology 78

Ratings Overview 78
Table: Pharmaceutical Risk/Reward Ratings Indicators 79

Weighting 80
Table: Weighting Of Components 80

Sources 80

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown


  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.


If you have a more general question about our products please try our



Our Clients

  • AB Sciex
  • Eli Lilly and Company
  • B. Braun Melsungen AG
  • Astellas Pharma, Inc.
  • Hologic Inc.
  • Merck & Co., Inc.